We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
Cap. Flow
+$4.56B
Cap. Flow %
5.05%
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344

Sector Composition

Rank Sector Weight
1 Financials 11.61%
2 Technology 10.97%
3 Healthcare 10.51%
4 Consumer Discretionary 7.19%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMTX
3901
DELISTED
Dimension Therapeutics, Inc
DMTX
$84K ﹤0.01%
+14,156
New +$108K
MCHX icon
3902
Marchex
MCHX
$79.3M
$82K ﹤0.01%
+25,841
New +$97.2K
LFWD icon
3903
ReWalk Robotics
LFWD
$19.6M
$82K ﹤0.01%
+6
New +$107K
CNTY icon
3904
Century Casinos
CNTY
$32.6M
$80K ﹤0.01%
12,973
-37,490
-74% -$224K
GAIN icon
3905
Gladstone Investment Corp
GAIN
$655M
$80K ﹤0.01%
+11,197
New +$78K
AGFS
3906
DELISTED
AgroFresh Solutions Inc
AGFS
$80K ﹤0.01%
15,099
-43,321
-74% -$241K
NVTA
3907
DELISTED
Invitae Corporation
NVTA
$79K ﹤0.01%
+10,689
New +$99.6K
DXLG icon
3908
Destination XL Group
DXLG
$34.3M
$77K ﹤0.01%
+16,890
New +$83.9K
WG
3909
DELISTED
Willbros Group
WG
$77K ﹤0.01%
30,121
-52,516
-64% -$145K
TNAV
3910
DELISTED
Telenav Inc.
TNAV
$76K ﹤0.01%
+14,731
New +$76.9K
OSIR
3911
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$76K ﹤0.01%
14,885
-8,398
-36% -$45.2K
GI
3912
DELISTED
EndoChoice Holdings, Inc.
GI
$75K ﹤0.01%
+15,251
New +$72.7K
WPRT
3913
Westport Fuel Systems
WPRT
$32.9M
$74K ﹤0.01%
+4,398
New +$94.7K
CYTR
3914
DELISTED
CytRx Corp
CYTR
$74K ﹤0.01%
5,508
+3,026
+122% +$50.3K
NMM icon
3915
Navios Maritime Partners
NMM
$2.25B
$73K ﹤0.01%
+3,767
New +$81K
ASXC
3916
DELISTED
Asensus Surgical, Inc.
ASXC
$73K ﹤0.01%
4,655
+2,821
+154% +$88.6K
ANTH
3917
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$73K ﹤0.01%
2,925
+606
+26% +$17.1K
ZAIS
3918
DELISTED
ZAIS Group Holdings, Inc.
ZAIS
$73K ﹤0.01%
+26,001
New +$68.6K
ELDN icon
3919
Eledon Pharmaceuticals
ELDN
$262M
$72K ﹤0.01%
+80
New +$88.3K
SOL
3920
DELISTED
Emeren Group
SOL
$72K ﹤0.01%
11,660
-31,800
-73% -$210K
ZDGE icon
3921
Zedge
ZDGE
$38.4M
$72K ﹤0.01%
+15,796
New +$66.1K
STML
3922
DELISTED
Stemline Therapeutics, Inc.
STML
$72K ﹤0.01%
+10,567
New +$66.7K
EGLT
3923
DELISTED
Egalet Corporation
EGLT
$72K ﹤0.01%
14,545
-14,219
-49% -$84.3K
PTX
3924
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$72K ﹤0.01%
16,069
+14,691
+1,066% +$95.9K
BPTH
3925
DELISTED
Bio-Path Holdings Inc
BPTH
$70K ﹤0.01%
9

Similar funds

Credit Suisse's Q2 2016 Portfolio in Review

As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.

  • Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
  • Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
  • Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
  • Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
  • Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
  • Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.